Reviva Pharmaceuticals Holdings RVPH
OTC RVPH
$0.34 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Reviva Pharmaceuticals Holdings (RVPH) Gains from Investment Securities (2018 - 2023)

Updated

Analysis

Reviva Pharmaceuticals Holdings (RVPH) Gains from Investment Securities (2018 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Reviva Pharmaceuticals Holdings 4.46 Mn -82.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -11,126.00
Mar 31, 2022 -89,010.00
Jun 30, 2021 189,146.00
Mar 31, 2021 923,480.00
Feb 29, 2020 18,708.00
Nov 30, 2019 -20,874.00
Aug 31, 2019 16,692.00
May 31, 2019 10,815.00
Feb 28, 2019 -9,212.00
Nov 30, 2018 -10,892.00
Aug 31, 2018 -4,055.00
API Access

Reviva Pharmaceuticals Holdings Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=RVPH&period=max&api_key=YOUR_API_KEY